JPH0818965B2 - Cosmetics - Google Patents
CosmeticsInfo
- Publication number
- JPH0818965B2 JPH0818965B2 JP16764489A JP16764489A JPH0818965B2 JP H0818965 B2 JPH0818965 B2 JP H0818965B2 JP 16764489 A JP16764489 A JP 16764489A JP 16764489 A JP16764489 A JP 16764489A JP H0818965 B2 JPH0818965 B2 JP H0818965B2
- Authority
- JP
- Japan
- Prior art keywords
- microcapsules
- cosmetic
- metal
- mixed
- alkaline earth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002537 cosmetic Substances 0.000 title claims description 37
- 239000003094 microcapsule Substances 0.000 claims description 33
- 239000003086 colorant Substances 0.000 claims description 29
- 239000000126 substance Substances 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 229920000642 polymer Polymers 0.000 claims description 11
- -1 alkaline earth metal carbonate Chemical class 0.000 claims description 10
- 229910052751 metal Inorganic materials 0.000 claims description 9
- 239000002184 metal Substances 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 9
- 229920003169 water-soluble polymer Polymers 0.000 claims description 9
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 8
- 229910052915 alkaline earth metal silicate Inorganic materials 0.000 claims description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 claims description 3
- 229910000287 alkaline earth metal oxide Inorganic materials 0.000 claims description 3
- 229910000316 alkaline earth metal phosphate Inorganic materials 0.000 claims description 3
- 150000004692 metal hydroxides Chemical class 0.000 claims description 3
- 150000004706 metal oxides Chemical class 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- 125000000129 anionic group Chemical group 0.000 claims description 2
- 150000001342 alkaline earth metals Chemical class 0.000 claims 1
- CYHOWEBNQPOWEI-UHFFFAOYSA-L calcium 3-carboxy-1-phenyldiazenylnaphthalen-2-olate Chemical compound OC=1C(=CC2=CC=CC=C2C1N=NC1=CC=CC=C1)C(=O)[O-].OC=1C(=CC2=CC=CC=C2C1N=NC1=CC=CC=C1)C(=O)[O-].[Ca+2] CYHOWEBNQPOWEI-UHFFFAOYSA-L 0.000 description 28
- 239000000463 material Substances 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 14
- 239000002585 base Substances 0.000 description 13
- 239000000839 emulsion Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 239000000049 pigment Substances 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 11
- 241000700198 Cavia Species 0.000 description 10
- 206010012442 Dermatitis contact Diseases 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 208000010247 contact dermatitis Diseases 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000006185 dispersion Substances 0.000 description 9
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 9
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 7
- 239000004115 Sodium Silicate Substances 0.000 description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 7
- 239000013566 allergen Substances 0.000 description 7
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 7
- 239000000377 silicon dioxide Substances 0.000 description 7
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 7
- 229910052911 sodium silicate Inorganic materials 0.000 description 7
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 239000006229 carbon black Substances 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 235000013980 iron oxide Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 235000010413 sodium alginate Nutrition 0.000 description 4
- 239000000661 sodium alginate Substances 0.000 description 4
- 229940005550 sodium alginate Drugs 0.000 description 4
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- 239000004147 Sorbitan trioleate Substances 0.000 description 3
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229910052910 alkali metal silicate Inorganic materials 0.000 description 3
- 208000030961 allergic reaction Diseases 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 239000000378 calcium silicate Substances 0.000 description 3
- 229910052918 calcium silicate Inorganic materials 0.000 description 3
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 230000000763 evoking effect Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 3
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 230000001235 sensitizing effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 235000019337 sorbitan trioleate Nutrition 0.000 description 3
- 229960000391 sorbitan trioleate Drugs 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- WFXHUBZUIFLWCV-UHFFFAOYSA-N (2,2-dimethyl-3-octanoyloxypropyl) octanoate Chemical compound CCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCC WFXHUBZUIFLWCV-UHFFFAOYSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- 208000019300 CLIPPERS Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 241001237745 Salamis Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000010306 acid treatment Methods 0.000 description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- IWOUKMZUPDVPGQ-UHFFFAOYSA-N barium nitrate Chemical compound [Ba+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O IWOUKMZUPDVPGQ-UHFFFAOYSA-N 0.000 description 2
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 150000002484 inorganic compounds Chemical class 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- LDHBWEYLDHLIBQ-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide;hydrate Chemical compound O.[OH-].[O-2].[Fe+3] LDHBWEYLDHLIBQ-UHFFFAOYSA-M 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- YIXJRHPUWRPCBB-UHFFFAOYSA-N magnesium nitrate Chemical compound [Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O YIXJRHPUWRPCBB-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 239000012860 organic pigment Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 235000015175 salami Nutrition 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004111 Potassium silicate Substances 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- 229910052936 alkali metal sulfate Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000009432 framing Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 201000005299 metal allergy Diseases 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- BDRTVPCFKSUHCJ-UHFFFAOYSA-N molecular hydrogen;potassium Chemical compound [K].[H][H] BDRTVPCFKSUHCJ-UHFFFAOYSA-N 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
- ATGAWOHQWWULNK-UHFFFAOYSA-I pentapotassium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [K+].[K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O ATGAWOHQWWULNK-UHFFFAOYSA-I 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- NNHHDJVEYQHLHG-UHFFFAOYSA-N potassium silicate Chemical compound [K+].[K+].[O-][Si]([O-])=O NNHHDJVEYQHLHG-UHFFFAOYSA-N 0.000 description 1
- 229910052913 potassium silicate Inorganic materials 0.000 description 1
- 235000019353 potassium silicate Nutrition 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 231100000202 sensitizing Toxicity 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000121 skin sensitizing Toxicity 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 235000019795 sodium metasilicate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 235000019794 sodium silicate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 150000005671 trienes Chemical class 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
【発明の詳細な説明】 (産業上の利用分野) 本発明は化粧料、特に接触皮膚炎の発生の抑制を意図
して開発された化粧料に関するものである。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a cosmetic, particularly a cosmetic developed with the intention of suppressing the occurrence of contact dermatitis.
(従来の技術及び発明が解決しようとする課題) 従来より、化粧料としては種々のものが使用されてい
るが、近年においていわゆる化粧品カブレと称される
「接触皮膚炎」なる皮膚疾患の発生が化粧料の使用にお
いて重要な問題となっている。(Prior Art and Problems to be Solved by the Invention) Conventionally, various kinds of cosmetics have been used, but in recent years, the occurrence of a skin disease called "contact dermatitis" called so-called cosmetic rash. It has become an important issue in the use of cosmetics.
この接触皮膚炎は、原因物質と皮膚との接触によって
生じるものと考えられ、たとえば口紅に配合されている
ある種のタール系色素や、ファンデーションに配合され
ている酸化鉄,粘土鉱物等に含有される不純物としての
金属類、とりわけクロム,ニッケル,コバルトが原因物
質であると推定されている。This contact dermatitis is considered to be caused by the contact between the causative substance and the skin. For example, it is contained in certain tar pigments that are mixed in lipsticks, iron oxides and clay minerals that are mixed in foundations. It is presumed that metals as impurities, especially chromium, nickel, and cobalt are causative substances.
特に、上記接触皮膚炎がアレルギー性の疾患であると
ころから、色素中のアレルゲンは最も重要な要員と認め
られ、その試験例等も実際に報告がなされている。In particular, since the contact dermatitis is an allergic disease, the allergen in the pigment is recognized as the most important person, and the test examples thereof have been actually reported.
本発明は、このような問題点に着目してなされたもの
で、上記のような接触皮膚炎の発生を抑制しうる化粧料
を提供することを課題とするものである。The present invention has been made in view of such problems, and an object thereof is to provide a cosmetic that can suppress the occurrence of the contact dermatitis as described above.
(課題を解決するための手段) 本発明は、このような課題を解決するために、上記の
ような原因物質としての着色料等の皮膚との直接接触を
避けるために、マイクロカプセルにより着色料等を封入
するという観点からなされたものである。(Means for Solving the Problems) In order to solve such problems, the present invention provides a coloring agent by microcapsules in order to avoid direct contact with the skin such as coloring agents as the above-mentioned causative substances. It was made from the viewpoint of enclosing etc.
すなわち、本発明の上記課題を解決するための手段
は、少なくとも一種の着色料を不溶性の高分子で被覆
し、且つその不溶性高分子で被覆された着色料を、アル
カリ土類金属珪酸塩,アルカリ土類金属炭酸塩,アルカ
リ土類金属硫酸塩,アルカリ土類金属リン酸塩,金属酸
化物,金属水酸化物,金属珪酸塩,及び金属炭酸塩の少
なくとも一種からなる壁物質に内包せしめた平均粒径が
0.1〜30μmのマイクロカプセルを配合したことにあ
る。That is, means for solving the above problems of the present invention, at least one colorant is coated with an insoluble polymer, and the colorant coated with the insoluble polymer, alkaline earth metal silicate, alkali Average contained in a wall material consisting of at least one of earth metal carbonate, alkaline earth metal sulfate, alkaline earth metal phosphate, metal oxide, metal hydroxide, metal silicate, and metal carbonate Particle size is
This is because microcapsules of 0.1 to 30 μm were blended.
尚、このような化粧料に配合されるマイクロカプセル
は、本発明者等が先に出願した特願昭63−2825号のマイ
クロカプセルの製造方法によって製造される。The microcapsules to be mixed with such cosmetics are manufactured by the method for manufacturing microcapsules of Japanese Patent Application No. 63-2825 previously filed by the present inventors.
すなわち、先ず着色料の表面に予め吸着性の水溶性高
分子を吸着させ、この水溶性高分子の吸着された着色料
を、アルカリ金属の珪酸塩若しくは炭酸塩,リン酸塩,
硫酸塩等の無機化合物の水溶性に懸濁,分散させ、水に
対する溶解度が5%以上の有機溶媒に前記分散液を混合
してW/O型乳濁液とし、次に前記選択された無機化合物
との水溶液反応によって水不溶性沈澱を生成しうるアル
カリ土類金属塩若しくは金属塩の水溶液を前記乳濁液と
混合することにより、水不溶性沈澱からなる微小中空状
の壁物質を形成し、その後、必要に応じて濾過,水洗す
ることにより、前記壁物質内に着色料が封入されてマイ
クロカプセルが製造されるのである。That is, first, an adsorbent water-soluble polymer is adsorbed on the surface of the colorant in advance, and the adsorbed colorant of the water-soluble polymer is treated with an alkali metal silicate or carbonate, phosphate,
An inorganic compound such as sulfate is suspended and dispersed in water, and the dispersion is mixed with an organic solvent having a solubility in water of 5% or more to prepare a W / O emulsion, and then the selected inorganic An aqueous solution of an alkaline earth metal salt or metal salt capable of forming a water-insoluble precipitate by reaction with a compound is mixed with the emulsion to form a micro hollow wall material consisting of the water-insoluble precipitate, then By optionally filtering and washing with water, the colorant is encapsulated in the wall substance to produce microcapsules.
そして、上記のような水不溶性沈澱が生成する反応に
より壁物質が形成される際に、上記水溶性高分子と金属
塩等の無機化合物との反応により、不溶性高分子が前記
壁物質の内側に同時に形成されることとなるのである。Then, when the wall substance is formed by the reaction of forming the water-insoluble precipitate as described above, the water-soluble polymer reacts with the inorganic compound such as a metal salt to cause the insoluble polymer to be deposited inside the wall substance. It will be formed at the same time.
このような製造に用いられる水溶性高分子としては、
カルボキシメチルセルロース,カゼインナトリウム,ア
ルギン酸ナトリウム,アラビアゴム等の陰イオン性水溶
性高分子が好ましい。As the water-soluble polymer used in such production,
Anionic water-soluble polymers such as carboxymethyl cellulose, sodium caseinate, sodium alginate and gum arabic are preferable.
また、水溶性高分子の量はその種類によっても異なる
が、有機顔料の重量に対して20〜200%であり、これよ
り少ない場合には、有機顔料は好適に水相に分散しな
い、一方、多すぎる場合には、W/O型乳濁液の安定性が
悪くなり、また粘度が増大しすぎて取扱いが困難とな
る。水溶性高分子の粘度については特に制限はないが、
高粘度のものが取扱いが困難なるため、低い粘度のもの
が好ましい。Further, the amount of the water-soluble polymer varies depending on its type, but is 20 to 200% with respect to the weight of the organic pigment, and if it is less than this, the organic pigment is not suitably dispersed in the aqueous phase, while, If the amount is too large, the stability of the W / O emulsion will be poor, and the viscosity will be too high, making handling difficult. There is no particular limitation on the viscosity of the water-soluble polymer,
Since a high-viscosity one is difficult to handle, a low-viscosity one is preferable.
さらに、上記のようにマイクロカプセルを製造する場
合に、アルカリ金属のケイ酸塩としては、たとえばJIS1
号ケイ酸ナトリウム,JIS2号ケイ酸ナトリウム,JIS3号ケ
イ酸ナトリウム,メタケイ酸ナトリウム,ケイ酸カリウ
ム(K2O・nSiO2,n=2〜3.8)等が例示され、また、ア
ルカリ金属の炭酸塩としては炭酸ナトリウム,炭酸水素
ナトリウム,炭酸カリウム等が例示され、また、アルカ
リ金属のリン酸塩としてはリン酸2水素ナトリウム,リ
ン酸水素2ナトリウム,リン酸3ナトリウム,リン酸2
水素カリウム,リン酸水素2カリウム,リン酸3カリウ
ムが例示され、さらに、アルカリ金属の硫酸塩としては
硫酸ナトリウム,硫酸カリウム等が例示される。Further, when producing the microcapsules as described above, as the alkali metal silicate, for example JIS1
No. Sodium silicate, JIS No. 2 sodium silicate, JIS No. 3 sodium silicate, sodium metasilicate, potassium silicate (K 2 O ・ nSiO 2 , n = 2 to 3.8), etc. are also exemplified, and alkali metal carbonates Examples thereof include sodium carbonate, sodium hydrogen carbonate, potassium carbonate, and the like. Examples of alkali metal phosphates include sodium dihydrogen phosphate, disodium hydrogen phosphate, trisodium phosphate, and phosphoric acid 2
Examples include potassium hydrogen, dipotassium hydrogen phosphate, and potassium triphosphate, and examples of alkali metal sulfates include sodium sulfate and potassium sulfate.
又、有機溶媒としては、n−ヘキサン,デカン,オク
タン等の脂肪族飽和炭化水素、又はトルエン,ベンゼ
ン,キシレン等の芳香族炭化水素、さらにはシクロヘキ
サン等の脂環式炭化水素等が挙げられる。Examples of the organic solvent include saturated aliphatic hydrocarbons such as n-hexane, decane and octane, aromatic hydrocarbons such as toluene, benzene and xylene, and alicyclic hydrocarbons such as cyclohexane.
これら各溶媒は、勿論1種単独で、又は2種以上併用
して使用することができる。Of course, these solvents may be used alone or in combination of two or more.
さらに、該製造方法に用いる乳化剤としては、好まし
くはHLB値が3.5〜6.0の範囲内にある非イオン界面活性
剤の使用ができる。代表的なものとしては、たとえば、
ソルビタンセスキオレエート,ソルビタンモノオレエー
ト,ポリオキシエチレンソルビタントリオレエート等が
ある。Further, as the emulsifier used in the production method, a nonionic surfactant having an HLB value in the range of 3.5 to 6.0 can be preferably used. As a typical example, for example,
Examples include sorbitan sesquioleate, sorbitan monooleate, and polyoxyethylene sorbitan trioleate.
さらに、乳濁液と混合される水溶液としては、塩化マ
グネシウム,塩化カルシウム,塩化バリウム,硝酸マグ
ネシウム,硝酸カルシウム,硝酸バリウム,硫酸亜鉛,
塩化亜鉛,硫酸アルミニウム,塩化アルミニウム,硝酸
アルミニウム等のアルカリ土類金属塩または金属塩水溶
液が例示される。Further, as an aqueous solution mixed with the emulsion, magnesium chloride, calcium chloride, barium chloride, magnesium nitrate, calcium nitrate, barium nitrate, zinc sulfate,
Examples thereof include alkaline earth metal salts or metal salt aqueous solutions of zinc chloride, aluminum sulfate, aluminum chloride, aluminum nitrate and the like.
ただし、上記アルカリ金属のケイ酸塩等や、有機溶
媒,乳化剤,アルカリ土類金属塩等の水溶液の種類は上
記のものに限定されない。However, the types of aqueous solutions of the above-mentioned alkali metal silicates, organic solvents, emulsifiers, alkaline earth metal salts, etc. are not limited to the above.
(作用) そして、本発明の化粧料においては、その化粧料中に
配合されている着色料が、上記のようなマイクロカプセ
ルの壁物質に内包されているため、その壁物質によって
着色料が皮膚に直接接触するのが阻止されることとな
る。(Function) In the cosmetic of the present invention, since the colorant contained in the cosmetic is included in the wall substance of the microcapsules as described above, the colorant is removed by the wall substance. Will be prevented from coming into direct contact with.
さらに重要な点は、上記のような壁物質は一般に多孔
性の物質であるため、上記のような着色料と皮膚との接
触は阻止できるが、着色料中のアレルゲンが上記壁物質
の細孔から溶脱するのを防止することはできない。しか
るに、本発明の化粧料では、上記着色料が壁物質の内側
でさらに不溶性高分子にて被覆されているため、その不
溶性高分子によってアレルゲンの脱落も防止されること
となるのである。More importantly, since the above-mentioned wall substance is generally a porous substance, it is possible to prevent contact between the colorant and the skin as described above, but the allergen in the colorant causes pores of the wall substance. It cannot prevent leaching from the. However, in the cosmetic of the present invention, since the colorant is further coated with the insoluble polymer inside the wall substance, the insoluble polymer also prevents the allergen from falling off.
これにより、接触皮膚炎の要因と認められる着色料の
皮膚への接触を防止できるばかりでなくアレルゲン自体
の皮膚への接触も防止できることとなる。This makes it possible to prevent not only the contact of the coloring agent, which is considered to be a factor of contact dermatitis, with the skin, but also the contact of the allergen itself with the skin.
(実施例) 以下、本発明の実施例について説明する。(Example) Hereinafter, the Example of this invention is described.
調製例1 先ず、一例(後述の実施例1)としての化粧料中に配
合される赤色219号(以下、R−219と略す)のシリカ壁
マイクロカプセルの調製例について説明する。Preparation Example 1 First, as an example (Example 1 described later), a preparation example of a silica wall microcapsule of Red No. 219 (hereinafter abbreviated as R-219) to be blended in a cosmetic will be described.
R−219(ブリリアントレーキレッドR)7.0gをメタ
ノール4mlで湿潤させ、水溶性高分子の一例としての2.5
%カルボキシメチルセルロース(CMCダイセル1110,ダイ
セル化学)及び1.0%アルゲン酸ナトリウム(ダックア
ルギンNSPLL,紀文フードケミファ)の混合水溶液150ml
を加えて撹拌し、上記R−219の分散液を調製する。R-219 (Brilliant Lake Red R) 7.0 g was moistened with 4 ml of methanol to give 2.5% as an example of water-soluble polymer.
% Carboxymethylcellulose (CMC Daicel 1110, Daicel Chemical) and 1.0% sodium alginate (Duck Algin NSPLL, Kibun Food Chemifa) mixed solution 150ml
Is added and stirred to prepare a dispersion liquid of R-219.
次に、この分散液150mlと2.4mol/の1号ケイ酸ナト
リウム(Na2O・2SiO2・xH2O)水溶液150mlとの混合し、
顔料を十分に分散させた後、乳化剤としてのソルビタン
セスキオレエートとポリオキシエチレン(20)ソルビタ
ントリオレエート(4:1)混合物の2%n−ヘキサン溶
液400mlに注ぎ、ホモミキサーで30秒間乳化し、W/O型乳
濁液を調製する。Then mixed with the dispersion 150ml and 2.4 mol / 1 sodium silicate No. of (Na 2 O · 2SiO 2 · xH 2 O) aqueous solution of 150ml,
After sufficiently dispersing the pigment, pour it into 400 ml of a 2% n-hexane solution of a sorbitan sesquioleate and polyoxyethylene (20) sorbitan trioleate (4: 1) mixture as an emulsifier and emulsify for 30 seconds with a homomixer. , W / O emulsion is prepared.
次に、この乳濁液を1.5mol/の塩化カルシウム水溶
液1500mlに注ぎ、30分間撹拌した後、1時間静置する。Next, this emulsion is poured into 1500 ml of a 1.5 mol / calcium chloride aqueous solution, stirred for 30 minutes, and allowed to stand for 1 hour.
その後、遠心分散により固液分離した後、濾過,水
洗,アルコール洗浄及び乾燥を行う。After that, solid-liquid separation is performed by centrifugal dispersion, followed by filtration, washing with water, washing with alcohol and drying.
これによって、ケイ酸カルシウムを主成分とする微小
中空状の壁物質の中空部にR−219の9.2重量%(球体重
量に対する重量%)を封入して構成された球状体である
平均粒径4.0μmのマイクロカプセル75.2gが得られた。As a result, 9.2 wt% of R-219 (wt% relative to the weight of the sphere) is enclosed in the hollow portion of the micro hollow wall material containing calcium silicate as the main component, and the average particle diameter is 4.0. 75.2 g of μm microcapsules were obtained.
また、該マイクロカプセルを再度水に懸濁させ撹拌し
ながら希塩酸を添加し、酸処理を行うことによって、ま
た必要に応じて水洗,乾燥を行うことにより、シリカを
主成分とする微小中空状の壁物質の中空部に上部R−21
9の12.0重量%(球体重量に対する重量%)を封入して
構成された球状体である平均粒径4.0μmのマイクロカ
プセル57.2gが得られた。In addition, the microcapsules are suspended in water again, diluted hydrochloric acid is added to the mixture while stirring, and acid treatment is carried out, and if necessary, washing and drying are carried out to obtain fine hollow particles containing silica as a main component. In the hollow part of the wall material, the upper part R-21
As a result, 57.2 g of microcapsules having an average particle diameter of 4.0 μm, which were spherical bodies constituted by encapsulating 12.0% by weight of 9 (% by weight based on the weight of the sphere), were obtained.
実施例1 本実施例は、上記調製例1のようにして調製されたマ
イクロカプセルを、口紅に配合した化粧料についての実
施例である。Example 1 This example is an example of a cosmetic composition in which the microcapsules prepared as in Preparation Example 1 above were mixed with lipstick.
その組成は次のとおりである。 Its composition is as follows.
成分 重量% 調製例1のマイクロカプセル 20.0 カルナウバロウ 1.6 セレシン 12.8 サラシミツロウ 3.2 オクチルドデカノール 14.0 トリ−2−エチルヘキサン酸グリセリン 14.0 ジイソステアリルマレート 16.2 ジオクタン酸ネオペンチルグリコール 18.0 香料 適量 防腐剤,酸化防止剤 微量 本実施例の化粧料を製造する場合には、上記を〜
の混合液の一部に加え、3本ローラで処理し、顔料部
とする。次に他の成分を混合し、加熱融解した後、上記
顔料部を加え、ホモミキサーで均一に分散させる。そし
て、分散後に型に流し込んで急冷し、スティック状にな
ったものを容器に差し込みフレーミングを行うことによ
って製造される。Ingredients% by weight Microcapsules of Preparation Example 20.0 Carnauba wax 1.6 Ceresin 12.8 Salami beeswax 3.2 Octyldodecanol 14.0 Glycerin tri-2-ethylhexanoate 14.0 Diisostearylmalate 16.2 Neopentyl glycol dioctanoate 18.0 Perfume Preservatives, antioxidants When producing the cosmetics of this example, the above
In addition to a part of the mixed liquid of (3), it is treated with three rollers to form a pigment part. Next, the other components are mixed, heated and melted, and then the above-mentioned pigment portion is added and uniformly dispersed with a homomixer. Then, after dispersion, the mixture is poured into a mold to be rapidly cooled, and a stick-shaped product is inserted into a container for framing.
本実施例の化粧料(口紅)を、R−219に感作してい
る女性パネラー10人に使用したところ、紅斑,浮腫等の
アレルギー反応を示す者は認められなかった。When the cosmetic (lipstick) of this Example was used on 10 female panelists who had been sensitized to R-219, no one showed an allergic reaction such as erythema or edema.
調製例2 次に、後術の実施例2の化粧料に配合される赤色226
号(以下、R−226と略す),赤色202号(以下、R−20
2と略す),カーボンブラック,及い酸化チタン内包シ
リカ壁マイクロカプセルの調製例について説明する。Preparation Example 2 Next, the red 226 compounded in the cosmetic of Example 2 of the postoperative technique.
No. (hereinafter abbreviated as R-226), Red No. 202 (hereinafter R-20
(Abbreviated as 2), carbon black, and a preparation example of titanium oxide-encapsulating silica wall microcapsules will be described.
R−226の6.53g,R−202の1.63g及びカーボンブラック
の0.16gを混合し、これをメタノール4mlで湿潤させ、水
溶性高分子の一例としての2.0%のカルボキシメチルセ
ルロース(CMCダイセル1110,ダイセル化学)及び1.5%
アルギン酸ナトリウム(ダックアルギンNSPLL,紀文フー
ドケミファ)の混合水溶液200mlを加えて撹拌し、上記
R−226,R−202,及びカーボンブラックの混合分散液を
調製する。R-226 (6.53 g), R-202 (1.63 g) and carbon black (0.16 g) were mixed and wetted with methanol (4 ml) to prepare 2.0% carboxymethyl cellulose (CMC Daicel 1110, Daicel). Chemistry) and 1.5%
200 ml of a mixed aqueous solution of sodium alginate (Duck Algin NSPLL, Kibun Food Chemifa) is added and stirred to prepare a mixed dispersion of R-226, R-202 and carbon black.
次に、この分散液200mlと2.4mol/の1号ケイ酸ナト
リウム(Na2O・2SiO2・xH2O)水溶液200mlとを混合し、
さらに酸化チタン8.16gを添加混合し、顔料を十分に分
散させた後、乳化剤としてのソルビタンセスキオレエー
トとポリオキシエチレン(20)ソルビタントリオレエー
ト(3:1)混合物の5%トリエン溶液600mlに注ぎ、ホモ
ミキサーで20秒間乳化し、W/O型乳濁液を調製する。Then mixed with the dispersion 200ml and 2.4 mol / 1 sodium silicate No. of (Na 2 O · 2SiO 2 · xH 2 O) aqueous solution of 200ml,
Further, 8.16 g of titanium oxide was added and mixed to sufficiently disperse the pigment, and then poured into 600 ml of a 5% triene solution of a mixture of sorbitan sesquioleate as an emulsifier and polyoxyethylene (20) sorbitan trioleate (3: 1). , Emulsify with a homomixer for 20 seconds to prepare a W / O type emulsion.
次に、この乳濁液を1.7mol/の塩化カルシウム水溶
液2000mlに注ぎ、30分間撹拌した後、2時間静置する。Next, this emulsion is poured into 2000 ml of a 1.7 mol / calcium chloride aqueous solution, stirred for 30 minutes, and allowed to stand for 2 hours.
その後、上記調製剤1と同様の操作を行い、ケイ酸カ
ルシウムを主成分とする微小中空状の壁物質の中空部に
上記R−226が6.0重量%,R−202が1.5重量%,カーボン
ブラックが0.15重量%,及び酸化チタンが7.5重量%そ
れぞれ封入して構成された球状体である平均粒径2.5μ
mのマイクロカプセル108.0gが得られた。Thereafter, the same operation as in the above Preparation 1 is carried out, and 6.0% by weight of R-226, 1.5% by weight of R-202, and carbon black are contained in the hollow portion of the fine hollow wall material containing calcium silicate as a main component. Is 0.15% by weight and titanium oxide is 7.5% by weight, respectively, and is a spherical body with an average particle size of 2.5μ.
108.0 g of m microcapsules were obtained.
また、調製例1と同様の酸処理を行うことにより、シ
リカを主成分とする微小中空状の壁物質の中空部に上記
R−226が8.0重量%,R−202が2.0重量%,カーボンブラ
ックが0.2重量%,及び酸化チタンが10.0重量%それぞ
れ封入して構成された球状体である平均粒径2.5μmの
マイクロカプセル81.0gが得られた。Further, by performing the same acid treatment as in Preparation Example 1, 8.0% by weight of R-226, 2.0% by weight of R-202, carbon black were added to the hollow portion of the fine hollow wall material containing silica as a main component. Was obtained, and 81.0 g of microcapsules having an average particle diameter of 2.5 μm, which were spherical bodies constituted by encapsulating 0.2% by weight and 10.0% by weight of titanium oxide, respectively, were obtained.
実施例2 本実施例は、上記調製例2のようにして調製されたマ
イクロカプセルを、口紅に配合した化粧料についての実
施例である。Example 2 This example is an example of a cosmetic in which the microcapsules prepared as in the above Preparation Example 2 were blended in lipstick.
その組成は次のとおりである。 Its composition is as follows.
成分 重量% 調製例2のマイクロカプセル 20.0 キャンデリラロウ 2.0 セレシン 13.0 サラシミツロウ 2.4 オクチルドデカノール 7.0 トリ−2−エチルヘキサン酸グリセリン 25.0 ジイソステアリルマレート 25.0 ジオクタン酸ネオペンチルグリコール 5.4 香料 適量 防腐剤,酸化防止剤 微量 尚、この化粧料の製造方法は、上記実施例1と同様で
あるため、その説明は省略する。Ingredients% by weight Microcapsules of Preparation Example 20.0 Candelilla wax 2.0 Ceresin 13.0 Salami beeswax 2.4 Octyldodecanol 7.0 Glycerin tri-2-ethylhexanoate 25.0 Diisostearylmalate 25.0 Neopentyl glycol dioctanoate 5.4 Perfume Suitable preservative, oxidation Inhibitor Trace amount Since the method for producing this cosmetic material is the same as that in Example 1 above, its explanation is omitted.
調製例3 次に、後述の実施例3の化粧料に配合される酸化チタ
ン,ベンガラ,黄酸化鉄,及び黒酸化鉄を内包するシリ
カ壁マイクロカプセルの調製例について説明する。Preparation Example 3 Next, a description will be given of a preparation example of silica wall microcapsules containing titanium oxide, red iron oxide, yellow iron oxide, and black iron oxide, which are mixed in the cosmetic material of Example 3 described later.
酸化チタン52.3g,ベンガラ1.6g,黄酸化鉄8.2g,及び黒
酸化鉄0.9gを混合し、これを水溶性高分子の一例として
の2.0%のカルボキシメチルセルロース(CMCダイセル11
07,ダイセル化学)及び1.0%アルギン酸ナトリウム(ダ
ックアルギンNSPLL,紀文フードケミファ)の混合水溶液
200mlを加えて撹拌し、上記酸化チタン,ベンガラ,黄
酸化鉄,及び黒酸化鉄の混合分散液を調製する。Titanium oxide (52.3 g), red iron oxide (1.6 g), yellow iron oxide (8.2 g) and black iron oxide (0.9 g) were mixed, and this was mixed with 2.0% carboxymethyl cellulose (CMC Daicel 11
07, Daicel Chemistry) and 1.0% sodium alginate (Duck Algin NSPLL, Kibun Food Chemifa) mixed solution
Add 200 ml and stir to prepare a mixed dispersion of the above titanium oxide, red iron oxide, yellow iron oxide, and black iron oxide.
次に、この分散液200mlと2.4mol/の1号ケイ酸ナト
リウム(Na2O・2SiO2・xH2O)水溶液200mlとを混合し、
顔料を十分に分散させた後、乳化剤としてのソルビタン
セスキオレエートとポリオキシエチレン(20)ソルビタ
ンモノオレエート(6:1)混合物の4%ベンゼン溶液700
mlに注ぎ、ホモミキサーで3分間乳化し、W/O型乳濁液
を調製する。Then mixed with the dispersion 200ml and 2.4 mol / 1 sodium silicate No. of (Na 2 O · 2SiO 2 · xH 2 O) aqueous solution of 200ml,
4% benzene solution 700 of sorbitan sesquioleate and polyoxyethylene (20) sorbitan monooleate (6: 1) mixture as emulsifier after well dispersed pigment
Pour the mixture into ml and emulsify for 3 minutes with a homomixer to prepare a W / O type emulsion.
次に、この乳濁液を1.6mol/の塩化マグネシウム水
溶液1800mlに注ぎ、30分間撹拌した後、遠心分離により
固液分離する。そして濾過,水洗,アルコール洗浄及び
乾燥を行う。Next, this emulsion is poured into 1800 ml of 1.6 mol / magnesium chloride aqueous solution, stirred for 30 minutes, and then subjected to solid-liquid separation by centrifugation. Then, filtration, water washing, alcohol washing and drying are performed.
このようにして得た粉末を再度水に懸濁させ、撹拌し
ながら希塩酸を添加し、pH4とし、その後、濾過,水
洗,乾燥を行うことによりシリカを主成分とする微小中
空状の壁物質の中空部に上記酸化チタン41.5重量%,ベ
ンガラ1.3重量%,黄酸化鉄6.5重量%,及び黒酸化鉄0.
7重量%を封入して構成された球状体である平均粒径2.2
μmのマイクロカプセル119.7gが得られた。The powder thus obtained is suspended again in water, diluted hydrochloric acid is added with stirring to adjust the pH to 4, and then filtered, washed with water, and dried to remove the fine hollow wall material containing silica as a main component. 41.5% by weight of titanium oxide, 1.3% by weight of red iron oxide, 6.5% by weight of yellow iron oxide, and 0.
Average particle size of 2.2, which is a spherical body composed of 7% by weight
119.7 g of microcapsules of μm were obtained.
実施例3 本実施例は、上記調製例3で調製されたマイクロカプ
セルを乳化ファンデーションに配合した化粧料について
の実施例である。Example 3 This example is an example of a cosmetic in which the microcapsules prepared in Preparation Example 3 above were mixed in an emulsion foundation.
成分 重量% 調製例3のマイクロカプセル 23.0 セタノール 1.75 サラシミツロウ 0.35 ワセリン 2.60 ミリスチン酸オクチルドデシル 8.00 親油型モノステアリン酸グリセリン 0.75 N−アシル−L−グルタミン酸ナトリウム 0.40 1,3−ブチレングリコール 5.40 グリセリン 5.30 キサンタンガム 0.17 精製水 残量 香料 適量 防腐剤,酸化防止剤 微量 本実施例の化粧料を製造する場合には、上記を,
の一部に添加し、十分に混練する(顔料部)。を
の一部に添加し溶解する(キサンタンガム部)。,
,,と,の残部と前記顔料部及びキサンタン
ガム部を混合し、加熱して70℃に保つ(水相)。また、
〜を混合し加熱融解して70℃に保つ(油相)。ホモ
ミキサーで水相中のを均一に分散させた後、水相に油
相を加え、ホモミキサーで均一に乳化し、その乳化後冷
却しながら掻き混ぜることによって上記化粧料が製造さ
れることとなる。Ingredients wt% Microcapsules of Preparation Example 3 23.0 Cetanol 1.75 Salix beeswax 0.35 Vaseline 2.60 Octyldodecyl myristate 8.00 Lipophilic glyceryl monostearate 0.75 N-acyl-L-glutamate sodium 0.40 1,3-Butylene glycol 5.40 Glycerin 5.30 Xanthan gum 0.17 Purified water Remaining amount Perfume Appropriate amount Preservative, antioxidant Trace amount When manufacturing the cosmetics of this example,
Add a part of the mixture and knead thoroughly (pigment part). Is added to a part of and dissolved (xanthan gum part). ,
,,, and the rest of the pigment, the pigment portion and the xanthan gum portion are mixed, heated and kept at 70 ° C. (aqueous phase). Also,
Are mixed, heated and melted, and kept at 70 ° C (oil phase). After evenly dispersing in the aqueous phase with a homomixer, the oil phase is added to the aqueous phase, the mixture is uniformly emulsified with a homomixer, and the cosmetic is produced by stirring while cooling after the emulsification. Become.
本実施例の化粧料を、コバルト,ニッケル等の金属ア
レルギー患者5人に使用したところ、アレルギー反応を
示す者は1人も認められなかった。When the cosmetics of this example were used on 5 patients with metal allergies such as cobalt and nickel, none of them showed any allergic reaction.
試験例 次に、上記のような化粧料中のマイクロカプセルの皮
膚接触アレルギー性試験の試験例について説明する。Test Example Next, a test example of the skin contact allergenicity test of the microcapsules in the cosmetic as described above will be described.
(1) 序 一般に皮膚感作性が大とされているR−219(ブリリ
アントレーキレッドR)を試料として、モルモットを用
いたアレルギー性試験により、本発明の化粧料(より詳
しくは化粧料中のマイクロカプセル)接触皮膚炎に対す
る効果について検討した。(1) Introduction Using the R-219 (Brilliant Lake Red R), which is generally considered to have a high skin sensitizing property, as a sample, an allergic test using guinea pigs was performed to find out that the cosmetic of the present invention The effect on contact dermatitis was examined.
その結果を以下に示す。 The results are shown below.
(2) 試験法 (イ)試料 (a) R−219(東色ピグメント製LOT.NO.5152)内包
のマイクロカプセル (調製例1のマイクロカプセル) R−219の内包率:12重量% 平均粒径:4μm (b) 比対照としてマイクロカプセル化していない未
処理のR−219(東色ピグメント製LOT.NO.5152)を用い
た。(2) Test method (a) Sample (a) Microcapsules encapsulating R-219 (TOT Pigment LOT.NO.5152) (microcapsules of Preparation Example 1) Encapsulation rate of R-219: 12% by weight Average particle size Diameter: 4 μm (b) Untreated R-219 (LOT.NO.5152, manufactured by Tohoku Pigment Co., Ltd.) which is not microencapsulated was used as a ratio control.
(ロ)感作濃度 (a) R−219…25%(基剤) (b) DNCB(2,4−ジニトロクロロベンゼン)…1%
(99.5%アルコール) (c) 対照群…基剤(12%PEG6000+88%PEG400)。(B) Sensitization concentration (a) R-219: 25% (base) (b) DNCB (2,4-dinitrochlorobenzene): 1%
(99.5% alcohol) (c) Control group: Base (12% PEG6000 + 88% PEG400).
(d) 対照群…アルコール(99.5%) (ハ)感作操作 (a) ハートレー系白色モルモット(雌)体重430〜5
90gの健康なものを使用した。(D) Control group: alcohol (99.5%) (c) Sensitization operation (a) Hartley white guinea pig (female) Weight 430-5
90g of healthy one was used.
(b) モルモットの頭部毛を電気バリカンと電気カミ
ソリで剃毛した。(B) The head hair of a guinea pig was shaved with an electric hair clipper and an electric razor.
(c) 剃毛した東部の2×4cmの区画4隅にFCA(Freu
nd's complete adjuvant):蒸留水の(1:1)乳化液を
0.1mlずつ皮内注射した。(C) The FCA (Freu
nd's complete adjuvant): Distilled water (1: 1) emulsion
0.1 ml each was injected intradermally.
(d) 区画内の表皮をセロファンテープでStripping
して軽い紅斑を生じさせ、その部位に各被検試料を塗布
し、その操作を隅日で5回繰り返した。(D) Stripping the epidermis in the compartment with cellophane tape
Then, light erythema was caused to occur, each test sample was applied to the site, and the operation was repeated 5 times in every day.
(ニ)惹起濃度 (a) R−219の25%で感作操作を行ったモルモット
に対して、それぞれ次の試料を塗布した。(D) Induced concentration (a) The following samples were applied to guinea pigs that had been sensitized with 25% of R-219.
R−219内包マイクロカプセル…基剤,1%,5%(モ
ルモット10匹) 未処理のR−219…基剤,1%,5%(モルモット10
匹) R−219内包マイクロカプセル…基剤,0.05%,0.2%
(モルモット9匹) 未処理のR−219…基剤,0.05%,0.2%(モルモット
9匹) 尚、上記,については、,との比較を容易に
するために、マイクロカプセルとしての濃度ではなく、
R−219としての濃度で調製した。R-219-encapsulated microcapsules ... Base, 1%, 5% (10 guinea pigs) Untreated R-219 ... Base, 1%, 5% (guinea pigs 10)
R) 219-encapsulated microcapsules ... Base, 0.05%, 0.2%
(9 guinea pigs) Untreated R-219 ... base, 0.05%, 0.2% (9 guinea pigs) For the above, in order to facilitate comparison with ,
Prepared at the concentration as R-219.
(b) DNCB1%で感作操作を行ったモルモット(5
匹)に対して、DNCB(アルコール,0.1%,1%)を塗布し
た。(B) Guinea pigs (5%) sensitized with 1% DNCB
DNCB (alcohol, 0.1%, 1%) was applied to each mouse).
(c) 対照群として、基剤で感作操作を行ったモルモ
ット(5匹)に対して、基剤,5%R−219内包マイクロ
カプセル,5%未処理のR−219をそれぞれ塗布した。(C) As a control group, the base, 5% R-219-encapsulated microcapsules, and 5% untreated R-219 were applied to guinea pigs (5 animals) sensitized with the base, respectively.
(d) 対照群として、アルコールで感作操作を行った
モルモット(4匹)に対して、アルコール,5%R−219
内包マイクロカプセル,5%未処理のR−219,1%DNCBを
それぞれ塗布した。(D) As a control group, guinea pigs (4 animals) sensitized with alcohol were treated with alcohol and 5% R-219.
Encapsulated microcapsules, 5% untreated R-219, and 1% DNCB were applied respectively.
(ホ)惹起操作 (a) 感作操作終了3週間後にモルモット背部毛を電
気バリカンと電気カミソリで剃毛し正中線を境にして該
当する各被検試料の惹起濃度,基剤,アルコールを塗布
した。(E) Inducing operation (a) Three weeks after the sensitizing operation, the back hair of the guinea pig was shaved with an electric clipper and an electric razor, and the inducing concentration, base, and alcohol of each relevant test sample were applied at the midline. did.
(b) 判定は24時間後、48時間後及び72時間後の3回
行い、紅斑,浮腫について観察した。(B) The determination was performed three times at 24 hours, 48 hours and 72 hours, and erythema and edema were observed.
(3) 結果 モルモット皮膚接触アレルギー製試験についての結果
を以下に示す。(3) Results The results of the guinea pig skin contact allergy test are shown below.
上記表1及び表2からも明らかなように、R−219MC
(R−219を内包したマイクロカプセル)については、
いずれの惹起濃度と基剤もアレルギー性を認めるものは
なかった。 As is clear from Tables 1 and 2 above, R-219MC
Regarding (microcapsules containing R-219),
None of the evoked concentrations and bases were allergic.
これに対して、未処理R−219(マイクロカプセル化
していないR−219)については、上記表1及び表2に
示すように、惹起濃度の上昇とともに反応率,平均反応
強度も増大し、R−219濃度5%において反応率は90%
であった。On the other hand, as for untreated R-219 (R-219 which is not microencapsulated), as shown in Tables 1 and 2 above, the reaction rate and the average reaction strength increase with the increase of the evoked concentration. 90% reaction rate at −219 concentration of 5%
Met.
また、表3からも明らかなように、陽性対照に用いた
DNCBは従来とほぼ同様のアレルギー性反応を認め、従っ
て実験状態の異常のないことを示した。Further, as is clear from Table 3, it was used as a positive control.
DNCB showed almost the same allergic reaction as before, thus showing that there was no abnormal experimental condition.
さらに、表4に示すように、基剤とアルコールで感作
操作を行った対照群に各試料と基剤及びアルコールをも
って惹起操作を行ったが、いずれも反応を認めることは
なく、陰性であった。Further, as shown in Table 4, a control group, which was sensitized with a base and alcohol, was evoked with each sample, the base and alcohol, but no reaction was observed and it was negative. It was
尚、上記各表中、反応率や平均反応強度は次の式で表
される。In each of the above tables, the reaction rate and average reaction intensity are represented by the following formula.
尚、上記実施例では、微小中空状の壁物質としてケイ
酸カルシウムやシリカを用いたが、この壁物質の材質も
上記実施例に限定されるものではなく、要は、アルカリ
土類金属珪酸塩,アルカリ土類金属炭酸塩,アルカリ土
類金属硫酸塩,アルカリ土類金属リン酸塩,金属酸化
物,金属水酸化物,金属珪酸塩,及び金属炭酸塩の少な
くとも一種が壁物質として使用されていればよい。 In the above examples, calcium silicate or silica was used as the micro hollow wall material, but the material of this wall material is not limited to the above examples, and the point is that the alkaline earth metal silicate is used. , At least one of alkaline earth metal carbonates, alkaline earth metal sulfates, alkaline earth metal phosphates, metal oxides, metal hydroxides, metal silicates, and metal carbonates are used as wall materials Just do it.
また、着色料の種類も該実施例のR−219やR−226等
に限定されるものではなく、各種の色素等の着色料を使
用することが可能である。Further, the type of colorant is not limited to R-219, R-226 and the like in the examples, and colorants such as various dyes can be used.
さらに、体質顔料を着色料とともに壁物質内に内包し
てもよい。Further, an extender pigment may be included in the wall substance together with the colorant.
要は、少なくとも1種の着色料が壁物質に内包されて
いればよいのである。The point is that at least one colorant is included in the wall substance.
さらに、化粧料の基剤の成分の種類や組成比率等も上
記実施例に限定されるものではなく、化粧料の種類に応
じて任意に変更可能である。Furthermore, the types and composition ratios of the components of the base material of the cosmetic are not limited to those in the above examples, and can be arbitrarily changed according to the type of cosmetic.
(発明の効果) 叙上のように、本発明においては、化粧料中に配合さ
れている着色料がマイクロカプセルの壁物質に内包され
ているため、その壁物質によって着色料が皮膚に直接接
触するのが阻止されることとなる。(Effects of the Invention) As described above, in the present invention, since the colorant contained in the cosmetic is included in the wall substance of the microcapsule, the colorant directly contacts the skin by the wall substance. Will be prevented.
さらに、上記着色料が壁物質の内側でさらに不溶性高
分子にて被覆されているため、壁物質が多孔性の物質で
あったとしても、上記不溶性高分子によって着色料中の
アレルゲンの溶脱も防止されることとなる。Furthermore, since the colorant is further coated with an insoluble polymer inside the wall substance, even if the wall substance is a porous substance, the insoluble polymer prevents the leaching of allergen in the colorant. Will be done.
従って、接触皮膚炎の要因と認められる着色料の皮膚
への接触を防止できるばかりでなく、重要な要因と認め
られていたアレルゲン自体の皮膚への接触も防止できる
ために、これらの要因を根本的に解決することができ、
接触皮膚炎に対する抑制防止効果が非常に優れた化粧料
を提供できるという格別顕著な効果を有するに至った。Therefore, it is possible to prevent not only the contact of the coloring agent, which is recognized as a factor of contact dermatitis, with the skin, but also the contact of the allergen itself, which has been recognized as an important factor, with the skin. Can be solved
The present invention has a particularly remarkable effect of being able to provide a cosmetic material having an excellent effect of suppressing contact dermatitis.
そして、上述のように皮膚への着色料(アレルゲン)
の接触が阻止される結果、化粧料使用前に使用者がすで
に化粧料中の着色料に感作している場合であっても、そ
の後に本発明の化粧料を使用する限り、アレルギーの惹
起性は従来に比べて著しく低下することとなり、また、
使用者が未だ着色料に感作していない場合には、その後
に本発明の化粧料を使用する限り、着色料の感作性その
ものを低下されることができ、従って、化粧料使用前の
感作性の有無、すなわち、使用者の体内に着色料による
抗体が生じているか否かにかかわらず本発明の化粧料の
使用により接触皮膚炎の発生が抑制されるのである。And, as mentioned above, coloring agents (allergens) to the skin
As a result of the prevention of contact with the skin, even if the user has already been sensitized to the colorant in the cosmetic before using the cosmetic, as long as the cosmetic of the present invention is used thereafter, it causes allergies. Is significantly lower than before, and
If the user has not yet been sensitized to the coloring agent, the sensitizing property of the coloring agent itself can be reduced as long as the cosmetic of the present invention is used thereafter, and therefore, before the use of the cosmetic agent, The use of the cosmetic of the present invention suppresses the occurrence of contact dermatitis regardless of whether or not sensitization is present, that is, whether or not an antibody is produced by the coloring agent in the body of the user.
第1図〜第4図はR−219内包のマイクロカプセルと未
処理のR−219のモルモット皮膚接触アレルギー性試験
の結果を示す図であり、第1図は塗布48時間後の反応率
とR−219濃度の関係を示すグラフ、第2図は塗布48時
間後の平均反応強度とR−219濃度との関係を示すグラ
フ、第3図は塗布72時間後の反応率とR−219濃度の関
係を示すグラフ、第4図は塗布72時間後の平均反応強度
のグラフとR−219濃度との関係を示すグラフ。1 to 4 are diagrams showing the results of the skin contact allergenicity test of R-219-encapsulated microcapsules and untreated R-219 in guinea pigs, and FIG. 1 shows the reaction rate and R after 48 hours from application. Fig. 2 is a graph showing the relationship between the -219 concentration, Fig. 2 is a graph showing the relationship between the average reaction intensity 48 hours after the application and R-219 concentration, and Fig. 3 is the reaction rate 72 hours after the application and the R-219 concentration. Fig. 4 is a graph showing the relationship, and Fig. 4 is a graph showing the relationship between the average reaction intensity 72 hours after application and the R-219 concentration.
───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 昭63−54310(JP,A) 特開 平1−180243(JP,A) ─────────────────────────────────────────────────── --Continued from the front page (56) References JP-A-63-54310 (JP, A) JP-A-1-180243 (JP, A)
Claims (2)
で被覆し、且つその不溶性高分子で被覆された着色料
を、アルカリ土類金属珪酸塩,アルカリ土類金属炭酸
塩,アルカリ土類金属硫酸塩,アルカリ土類金属リン酸
塩,金属酸化物,金属水酸化物,金属珪酸塩,及び金属
炭酸塩の少なくとも一種からなる壁物質に内包せしめた
平均粒径が0.1〜30μmのマイクロカプセルを配合した
ことを特徴とする化粧料。1. At least one colorant coated with an insoluble polymer, and the colorant coated with the insoluble polymer is an alkaline earth metal silicate, an alkaline earth metal carbonate, or an alkaline earth metal. Microcapsules with an average particle size of 0.1 to 30 μm encapsulated in a wall substance composed of at least one of sulfate, alkaline earth metal phosphate, metal oxide, metal hydroxide, metal silicate, and metal carbonate. Cosmetics characterized by being blended.
分子と、金属塩との反応によって生成される高分子であ
る請求項1記載の化粧料。2. The cosmetic according to claim 1, wherein the insoluble polymer is a polymer produced by a reaction between an anionic water-soluble polymer and a metal salt.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16764489A JPH0818965B2 (en) | 1989-06-29 | 1989-06-29 | Cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16764489A JPH0818965B2 (en) | 1989-06-29 | 1989-06-29 | Cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0334910A JPH0334910A (en) | 1991-02-14 |
| JPH0818965B2 true JPH0818965B2 (en) | 1996-02-28 |
Family
ID=15853589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16764489A Expired - Lifetime JPH0818965B2 (en) | 1989-06-29 | 1989-06-29 | Cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0818965B2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100725176B1 (en) * | 2000-04-14 | 2007-06-07 | 주식회사 만도 | Car Stabilizer |
| KR101914051B1 (en) * | 2018-07-13 | 2018-12-28 | (주)바이오제닉스 | Double capsule composition for containing charcoal and manufacturing method for the same |
| JP2024078972A (en) * | 2022-11-30 | 2024-06-11 | 星和電機株式会社 | Dispersants and dispersions for sparingly soluble or insoluble substances |
-
1989
- 1989-06-29 JP JP16764489A patent/JPH0818965B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0334910A (en) | 1991-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102170867B (en) | New controlled release active agent carrier | |
| JP5690567B2 (en) | Hydrogel particles | |
| IE894093L (en) | Cosmetic or pharmaceutical composition containing¹microspheres of polymer or of fatty substances filled with¹at least one active product | |
| JP6681918B2 (en) | Capsule manufacturing method | |
| JP2686484B2 (en) | Ultraviolet absorbent-containing microcapsules, method for producing the same, and cosmetics containing the microcapsules | |
| JPH0416212B2 (en) | ||
| JPH03267140A (en) | Microcapsule containing coloring matter, ultraviolet ray absorber and antioxidant, production of this microcapsule and cosmetics compounded with this microcapsule | |
| JP4637991B2 (en) | Microcapsule and manufacturing method thereof | |
| JP2002504425A (en) | Matrix for producing microparticles or nanoparticles, method for producing said particles and particles obtained | |
| JP4637992B2 (en) | Microcapsule and manufacturing method thereof | |
| JPH02251240A (en) | Ultraviolet absorber included microcapsule, preparation thereof and cosmetics containing same microcapsule | |
| JPH0818965B2 (en) | Cosmetics | |
| JP4637993B2 (en) | Microcapsule and manufacturing method thereof | |
| JP3555937B2 (en) | Method for producing hydrogel particles | |
| JPH053449B2 (en) | ||
| JPH041118A (en) | Cosmetic | |
| JP2779236B2 (en) | Water-dispersible lecithin | |
| JPH02200611A (en) | Skin cream with self-emulsifiability | |
| JPH1129433A (en) | Cosmetic containing capsule and its production | |
| JP2024545680A (en) | Chinese herbal active ingredient @ cyst complex having hair growth effect, its preparation method and its use | |
| JPH0140806B2 (en) | ||
| JP2003001095A (en) | Method for producing soft microsphere gel which easily disintegrates by rubbing | |
| KR101136839B1 (en) | Cosmetic composition for wash-off oil type face mask pack containing Lava powder and arginic acid as an effective component | |
| JP5388561B2 (en) | Method for producing hydrogel particles | |
| JP2504064B2 (en) | Cosmetics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080228 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090228 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 14 Free format text: PAYMENT UNTIL: 20100228 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 14 Free format text: PAYMENT UNTIL: 20100228 |